4-Hydroxypiperidines and Their Flexible 3-(Amino) propyloxy Analogues as Non-Imidazole Histamine H3 Receptor Antagonist: Further Structure-Activity Relationship Exploration and In Vitro and In Vivo Pharmacological Evaluation

Presynaptic histamine H-3 receptors (H3R) act as auto-or heteroreceptors controlling, respectively, the release of histamine and of other neurotransmitters in the central nervous system (CNS). The extracellular levels of several neurotransmitters are enhanced by H3R antagonists, and there is a great interest for potent, brain-penetrating H-3 receptor antagonists/inverse agonists to compensate for the neurotransmitter deficits present in various neurological disorders. We have shown that 1-[(benzylfuran-2-yl) methyl] piperidinyl-4-oxyl-and benzyl-derivatives of N-propylpentan-1-amines exhibit high in vitro potencies toward the guinea pig H-3 receptor (jejunum), with pA(2) = 8.47 and 7.79, respectively (the reference compound used was thioperamide with pA(2) = 8.67). Furthermore, following the replacement of 4-hydroxypiperidine with a 3-(methylamino) propyloxy chain, the pA(2) value for the first group decreased, whereas it increased for the second group. Here, we present data on the impact of elongating the aliphatic chain between the nitrogen of 4-hydroxypiperidine or 3-(methylamino) propan-1-ol and the lipophilic residue. Additionally, the most active compound in this series of non-imidazole H-3 receptor antagonists/inverse agonists, i.e., ADS-003, was evaluated for its affinity to the recombinant rat and human histamine H-3 receptors transiently expressed in HEK-293T cells. It was shown that ADS-003, given parenterally for 5 days, reduced the food intake of rats, as well as changed histamine and noradrenaline concentrations in the rats' brain in a manner and degree similar to the reference H-3 antagonist Ciproxifan.